Health Care & Life Sciences » Pharmaceuticals | NanoCarrier Co. Ltd.

NanoCarrier Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
472,197.00
675,801.00
243,344.00
218,694.00
259,097.00
496,732
Cost of Goods Sold (COGS) incl. D&A
182,496.00
212,788.00
34,150.00
61,670.00
67,990.00
79,891
Gross Income
289,701.00
463,013.00
209,194.00
157,024.00
191,107.00
416,841
SG&A Expense
1,265,070.00
1,517,529.00
2,223,890.00
2,779,601.00
5,443,898.00
2,155,219
EBIT
1,043,447.00
1,108,227.00
2,082,678.00
2,712,219.00
5,351,438.00
1,802,313
Unusual Expense
16,249.00
33,695.00
152,716.00
53,296.00
108,674.00
30,165
Non Operating Income/Expense
10,341.00
907,873.00
349,220.00
31,403.00
12,956.00
10,760
Interest Expense
-
-
4,823.00
-
-
-
Pretax Income
1,111,267.00
205,644.00
2,533,922.00
2,672,419.00
5,413,178.00
1,804,880
Income Tax
2,420.00
1,512.00
3,226.00
3,630.00
3,630.00
3,630
Consolidated Net Income
1,113,687.00
207,156.00
2,537,148.00
2,676,049.00
5,416,808.00
1,808,510
Net Income
1,113,687.00
207,156.00
2,537,148.00
2,676,049.00
5,416,808.00
1,808,510
Net Income After Extraordinaries
1,113,687.00
207,156.00
2,537,148.00
2,676,049.00
5,416,808.00
1,808,510
Net Income Available to Common
1,113,687.00
207,156.00
2,537,148.00
2,676,049.00
5,416,808.00
1,808,510
EPS (Basic)
30.44
5.12
59.53
62.07
125.39
39.14
Basic Shares Outstanding
36,581.30
40,455.50
42,621.20
43,114.10
43,200.30
46,209.10
EPS (Diluted)
30.44
5.12
59.53
62.07
125.39
39.14
Diluted Shares Outstanding
36,581.30
40,455.50
42,621.20
43,114.10
43,200.30
46,209.10
EBITDA
1,037,538.00
1,088,121.00
2,053,053.00
2,689,672.00
5,323,749.00
1,792,084
Other Operating Expense
68,078.00
53,711.00
67,982.00
89,642.00
98,647.00
63,935
Non-Operating Interest Income
17,686.00
28,405.00
55,515.00
61,694.00
33,977.00
16,838

About NanoCarrier Co.

View Profile
Address
144-15 Chuo
Kashiwa Chiba 277
Japan
Employees -
Website http://www.nanocarrier.co.jp
Updated 07/08/2019
NanoCarrier Co., Ltd. engages in the research, development, and production of pharmaceutical products through the use of micellar nanoparticles technology. These products are mainly used for cancer therapy. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Kashiwa, Japan.